Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List
Medical Marijuana Program Connection
JANUARY 18, 2023
BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today. Read More
Let's personalize your content